Global Atorvastatin market size is expected to reach $19.57 billion by 2029 at 10.5%, segmented as by chemical synthesis, traditional chemical synthesis of atorvastatin, semi-synthetic atorvastatin production
Read More
Global Atenolol market size is expected to reach $17.16 billion by 2029 at 8.3%, segmented as by 98% purity, atenolol with 98% purity for pharmaceutical formulations, atenolol 98% purity for generic drug production
Read More
Global Assisted Living Technologies market size is expected to reach $16.74 billion by 2029 at 16.4%, segmented as by hardware, wearable devices (smartwatches, health trackers), sensors (motion, pressure, temperature)
Read More
Global Assisted Living Facility And Neurorehabilitation market size is expected to reach $69.74 billion by 2029 at 7.8%, segmented as by women, elderly women, women with cognitive disorders, women with physical disabilities
Read More
Global Aseptic Sampling market size is expected to reach $1.5 billion by 2029 at 11.3%, segmented as by manual aseptic sampling, single-use manual sampling, reusable manual sampling
Read More
Global Artificial Saliva market size is expected to reach $3.72 billion by 2029 at 13.7%, segmented as by oral spray, non-alcoholic oral spray, alcohol-based oral spray
Read More
Global Artificial Pancreas Device System market size is expected to reach $3.48 billion by 2029 at 13.9%, segmented as by threshold suspend device systems, insulin pump with threshold suspend, continuous glucose monitoring (cgm) integrated systems
Read More
Global Artificial Intelligence (AI) Radiology Tool market size is expected to reach $3.4 billion by 2029 at 18%, segmented as by diagnostic radiology, ai for image interpretation (detecting fractures, tumors, or abnormalities)
Read More
Global Appendicitis Treatment market size is expected to reach $5.72 billion by 2029 at 6.8%, segmented as by acute appendicitis, surgical treatment (appendectomy), non-surgical treatment (antibiotics and observation)
Read More
Global Aplastic Anemia market size is expected to reach $8.84 billion by 2029 at 5.9%, segmented as by disease type, acquired aplastic anemia, inherited bone marrow failure syndromes
Read More